The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.

The market is mainly driven by the significant applications of Biological Drugs in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Others,, are propelling Biological Drugs market. Therapeutic Protein, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monoclonal Antibody segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biological Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Biological Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Biological Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biological Drugs sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Biological Drugs covered in this report include Bristol-Myers Squibb, Eli Lilly, Takeda, Pfizer, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Merck and Abbott Laboratories, etc.

The global Biological Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Bristol-Myers Squibb

Eli Lilly

Takeda

Pfizer

Amgen

F. Hoffmann-La Roche

Johnson & Johnson

Merck

Abbott Laboratories

Baxter

Novartis

Biogen

GlaxoSmithKline

Scope of Biological Drugs - Market Report

Report Metric	Details
Report Name	Biological Drugs - Market
Forecasted market size in 2029	US$ 508960 million
CAGR	8.2%
Forecasted years	2023 - 2029
Global Biological Drugs market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biological Drugs market, Segment by Type:	Therapeutic Protein Monoclonal Antibody Vaccine Others
Global Biological Drugs market, by Application	Hospitals Ambulatory Surgical Centers Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Biological Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Biological Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Biological Drugs - Market size in 2029?

Ans: The Biological Drugs - Market size in 2029 will be US$ 508960 million.

What are the Application segmentation covered in the Biological Drugs - Market report?

Ans: The Applications covered in the Biological Drugs - Market report are Hospitals, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Biological Drugs - Market report?

Ans: The Types covered in the Biological Drugs - Market report are Therapeutic Protein, Monoclonal Antibody, Vaccine, Others

1 Biological Drugs Market Overview

1.1 Biological Drugs Product Overview

1.2 Biological Drugs Market Segment by Type

1.2.1 Therapeutic Protein

1.2.2 Monoclonal Antibody

1.2.3 Vaccine

1.2.4 Others

1.3 Global Biological Drugs Market Size by Type

1.3.1 Global Biological Drugs Market Size Overview by Type (2018-2029)

1.3.2 Global Biological Drugs Historic Market Size Review by Type (2018-2023)

1.3.3 Global Biological Drugs Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Biological Drugs Sales Breakdown by Type (2018-2023)

1.4.2 Europe Biological Drugs Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Biological Drugs Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Biological Drugs Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Biological Drugs Sales Breakdown by Type (2018-2023)

2 Global Biological Drugs Market Competition by Company

2.1 Global Top Players by Biological Drugs Sales (2018-2023)

2.2 Global Top Players by Biological Drugs Revenue (2018-2023)

2.3 Global Top Players by Biological Drugs Price (2018-2023)

2.4 Global Top Manufacturers Biological Drugs Manufacturing Base Distribution, Sales Area, Product Type

2.5 Biological Drugs Market Competitive Situation and Trends

2.5.1 Biological Drugs Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Biological Drugs Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biological Drugs as of 2022)

2.7 Date of Key Manufacturers Enter into Biological Drugs Market

2.8 Key Manufacturers Biological Drugs Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Biological Drugs Status and Outlook by Region

3.1 Global Biological Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Biological Drugs Historic Market Size by Region

3.2.1 Global Biological Drugs Sales in Volume by Region (2018-2023)

3.2.2 Global Biological Drugs Sales in Value by Region (2018-2023)

3.2.3 Global Biological Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Biological Drugs Forecasted Market Size by Region

3.3.1 Global Biological Drugs Sales in Volume by Region (2024-2029)

3.3.2 Global Biological Drugs Sales in Value by Region (2024-2029)

3.3.3 Global Biological Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Biological Drugs by Application

4.1 Biological Drugs Market Segment by Application

4.1.1 Hospitals

4.1.2 Ambulatory Surgical Centers

4.1.3 Others

4.2 Global Biological Drugs Market Size by Application

4.2.1 Global Biological Drugs Market Size Overview by Application (2018-2029)

4.2.2 Global Biological Drugs Historic Market Size Review by Application (2018-2023)

4.2.3 Global Biological Drugs Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Biological Drugs Sales Breakdown by Application (2018-2023)

4.3.2 Europe Biological Drugs Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Biological Drugs Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Biological Drugs Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Biological Drugs Sales Breakdown by Application (2018-2023)

5 North America Biological Drugs by Country

5.1 North America Biological Drugs Historic Market Size by Country

5.1.1 North America Biological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Biological Drugs Sales in Volume by Country (2018-2023)

5.1.3 North America Biological Drugs Sales in Value by Country (2018-2023)

5.2 North America Biological Drugs Forecasted Market Size by Country

5.2.1 North America Biological Drugs Sales in Volume by Country (2024-2029)

5.2.2 North America Biological Drugs Sales in Value by Country (2024-2029)

6 Europe Biological Drugs by Country

6.1 Europe Biological Drugs Historic Market Size by Country

6.1.1 Europe Biological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Biological Drugs Sales in Volume by Country (2018-2023)

6.1.3 Europe Biological Drugs Sales in Value by Country (2018-2023)

6.2 Europe Biological Drugs Forecasted Market Size by Country

6.2.1 Europe Biological Drugs Sales in Volume by Country (2024-2029)

6.2.2 Europe Biological Drugs Sales in Value by Country (2024-2029)

7 Asia-Pacific Biological Drugs by Region

7.1 Asia-Pacific Biological Drugs Historic Market Size by Region

7.1.1 Asia-Pacific Biological Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Biological Drugs Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Biological Drugs Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Biological Drugs Forecasted Market Size by Region

7.2.1 Asia-Pacific Biological Drugs Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Biological Drugs Sales in Value by Region (2024-2029)

8 Latin America Biological Drugs by Country

8.1 Latin America Biological Drugs Historic Market Size by Country

8.1.1 Latin America Biological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Biological Drugs Sales in Volume by Country (2018-2023)

8.1.3 Latin America Biological Drugs Sales in Value by Country (2018-2023)

8.2 Latin America Biological Drugs Forecasted Market Size by Country

8.2.1 Latin America Biological Drugs Sales in Volume by Country (2024-2029)

8.2.2 Latin America Biological Drugs Sales in Value by Country (2024-2029)

9 Middle East and Africa Biological Drugs by Country

9.1 Middle East and Africa Biological Drugs Historic Market Size by Country

9.1.1 Middle East and Africa Biological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Biological Drugs Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Biological Drugs Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Biological Drugs Forecasted Market Size by Country

9.2.1 Middle East and Africa Biological Drugs Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Biological Drugs Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Bristol-Myers Squibb

10.1.1 Bristol-Myers Squibb Company Information

10.1.2 Bristol-Myers Squibb Introduction and Business Overview

10.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Bristol-Myers Squibb Biological Drugs Products Offered

10.1.5 Bristol-Myers Squibb Recent Development

10.2 Eli Lilly

10.2.1 Eli Lilly Company Information

10.2.2 Eli Lilly Introduction and Business Overview

10.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Eli Lilly Biological Drugs Products Offered

10.2.5 Eli Lilly Recent Development

10.3 Takeda

10.3.1 Takeda Company Information

10.3.2 Takeda Introduction and Business Overview

10.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Takeda Biological Drugs Products Offered

10.3.5 Takeda Recent Development

10.4 Pfizer

10.4.1 Pfizer Company Information

10.4.2 Pfizer Introduction and Business Overview

10.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Pfizer Biological Drugs Products Offered

10.4.5 Pfizer Recent Development

10.5 Amgen

10.5.1 Amgen Company Information

10.5.2 Amgen Introduction and Business Overview

10.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Amgen Biological Drugs Products Offered

10.5.5 Amgen Recent Development

10.6 F. Hoffmann-La Roche

10.6.1 F. Hoffmann-La Roche Company Information

10.6.2 F. Hoffmann-La Roche Introduction and Business Overview

10.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2018-2023)

10.6.4 F. Hoffmann-La Roche Biological Drugs Products Offered

10.6.5 F. Hoffmann-La Roche Recent Development

10.7 Johnson & Johnson

10.7.1 Johnson & Johnson Company Information

10.7.2 Johnson & Johnson Introduction and Business Overview

10.7.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Johnson & Johnson Biological Drugs Products Offered

10.7.5 Johnson & Johnson Recent Development

10.8 Merck

10.8.1 Merck Company Information

10.8.2 Merck Introduction and Business Overview

10.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Merck Biological Drugs Products Offered

10.8.5 Merck Recent Development

10.9 Abbott Laboratories

10.9.1 Abbott Laboratories Company Information

10.9.2 Abbott Laboratories Introduction and Business Overview

10.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2018-2023)

10.9.4 Abbott Laboratories Biological Drugs Products Offered

10.9.5 Abbott Laboratories Recent Development

10.10 Baxter

10.10.1 Baxter Company Information

10.10.2 Baxter Introduction and Business Overview

10.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Baxter Biological Drugs Products Offered

10.10.5 Baxter Recent Development

10.11 Novartis

10.11.1 Novartis Company Information

10.11.2 Novartis Introduction and Business Overview

10.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2018-2023)

10.11.4 Novartis Biological Drugs Products Offered

10.11.5 Novartis Recent Development

10.12 Biogen

10.12.1 Biogen Company Information

10.12.2 Biogen Introduction and Business Overview

10.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2018-2023)

10.12.4 Biogen Biological Drugs Products Offered

10.12.5 Biogen Recent Development

10.13 GlaxoSmithKline

10.13.1 GlaxoSmithKline Company Information

10.13.2 GlaxoSmithKline Introduction and Business Overview

10.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2018-2023)

10.13.4 GlaxoSmithKline Biological Drugs Products Offered

10.13.5 GlaxoSmithKline Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Biological Drugs Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Biological Drugs Industrial Chain Analysis

11.4 Biological Drugs Market Dynamics

11.4.1 Biological Drugs Industry Trends

11.4.2 Biological Drugs Market Drivers

11.4.3 Biological Drugs Market Challenges

11.4.4 Biological Drugs Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Biological Drugs Distributors

12.3 Biological Drugs Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Major Company of Therapeutic Protein

Table 2. Major Company of Monoclonal Antibody

Table 3. Major Company of Vaccine

Table 4. Major Company of Others

Table 5. Global Biological Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 6. Global Biological Drugs Sales by Type (2018-2023) & (Units)

Table 7. Global Biological Drugs Sales Market Share in Volume by Type (2018-2023)

Table 8. Global Biological Drugs Sales by Type (2018-2023) & (US& Million)

Table 9. Global Biological Drugs Market Share in Value by Type (2018-2023)

Table 10. Global Biological Drugs Price by Type (2018-2023) & (USD/Unit)

Table 11. Global Biological Drugs Sales by Type (2024-2029) & (Units)

Table 12. Global Biological Drugs Sales Market Share in Volume by Type (2024-2029)

Table 13. Global Biological Drugs Sales by Type (2024-2029) & (US$ Million)

Table 14. Global Biological Drugs Sales Market Share in Value by Type (2024-2029)

Table 15. Global Biological Drugs Price by Type (2024-2029) & (USD/Unit)

Table 16. North America Biological Drugs Sales by Type (2018-2023) & (Units)

Table 17. North America Biological Drugs Sales by Type (2018-2023) & (US$ Million)

Table 18. Europe Biological Drugs Sales (Units) by Type (2018-2023)

Table 19. Europe Biological Drugs Sales by Type (2018-2023) & (US$ Million)

Table 20. Asia-Pacific Biological Drugs Sales (Units) by Type (2018-2023)

Table 21. Asia-Pacific Biological Drugs Sales by Type (2018-2023) & (US$ Million)

Table 22. Latin America Biological Drugs Sales (Units) by Type (2018-2023)

Table 23. Latin America Biological Drugs Sales by Type (2018-2023) & (US$ Million)

Table 24. Middle East and Africa Biological Drugs Sales (Units) by Type (2018-2023)

Table 25. Middle East and Africa Biological Drugs Sales by Type (2018-2023) & (US$ Million)

Table 26. Global Biological Drugs Sales by Company (2018-2023) & (Units)

Table 27. Global Biological Drugs Sales Share by Company (2018-2023)

Table 28. Global Biological Drugs Revenue by Company (2018-2023) & (US$ Million)

Table 29. Global Biological Drugs Revenue Share by Company (2018-2023)

Table 30. Global Market Biological Drugs Price by Company (2018-2023) & (USD/Unit)

Table 31. Global Biological Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 32. Global Biological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biological Drugs as of 2022)

Table 34. Date of Key Manufacturers Enter into Biological Drugs Market

Table 35. Key Manufacturers Biological Drugs Product Type

Table 36. Mergers & Acquisitions, Expansion Plans

Table 37. Global Biological Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 38. Global Biological Drugs Sales by Region (2018-2023) & (Units)

Table 39. Global Biological Drugs Sales Market Share in Volume by Region (2018-2023)

Table 40. Global Biological Drugs Sales by Region (2018-2023) & (US$ Million)

Table 41. Global Biological Drugs Sales Market Share in Value by Region (2018-2023)

Table 42. Global Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 43. Global Biological Drugs Sales by Region (2024-2029) & (Units)

Table 44. Global Biological Drugs Sales Market Share in Volume by Region (2024-2029)

Table 45. Global Biological Drugs Sales by Region (2024-2029) & (US$ Million)

Table 46. Global Biological Drugs Sales Market Share in Value by Region (2024-2029)

Table 47. Global Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)

Table 48. Global Biological Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 49. Global Biological Drugs Sales by Application (2018-2023) & (Units)

Table 50. Global Biological Drugs Sales Market Share in Volume by Application (2018-2023)

Table 51. Global Biological Drugs Sales by Application (2018-2023) & (US$ Million)

Table 52. Global Biological Drugs Sales Market Share in Value by Application (2018-2023)

Table 53. Global Biological Drugs Price by Application (2018-2023) & (USD/Unit)

Table 54. Global Biological Drugs Sales by Application (2024-2029) & (Units)

Table 55. Global Biological Drugs Sales Market Share in Volume by Application (2024-2029)

Table 56. Global Biological Drugs Sales by Application (2024-2029) & (US$ Million)

Table 57. Global Biological Drugs Sales Market Share in Value by Application (2024-2029)

Table 58. Global Biological Drugs Price by Application (2024-2029) & (USD/Unit)

Table 59. North America Biological Drugs Sales by Application (2018-2023) (Units)

Table 60. North America Biological Drugs Sales by Application (2018-2023) & (US$ Million)

Table 61. Europe Biological Drugs Sales by Application (2018-2023) (Units)

Table 62. Europe Biological Drugs Sales by Application (2018-2023) & (US$ Million)

Table 63. Asia-Pacific Biological Drugs Sales by Application (2018-2023) (Units)

Table 64. Asia-Pacific Biological Drugs Sales by Application (2018-2023) & (US$ Million)

Table 65. Latin America Biological Drugs Sales by Application (2018-2023) (Units)

Table 66. Latin America Biological Drugs Sales by Application (2018-2023) & (US$ Million)

Table 67. Middle East and Africa Biological Drugs Sales by Application (2018-2023) (Units)

Table 68. Middle East and Africa Biological Drugs Sales by Application (2018-2023) & (US$ Million)

Table 69. North America Biological Drugs Sales by Country (2018-2023) & (Units)

Table 70. North America Biological Drugs Sales Market Share in Volume by Country (2018-2023)

Table 71. North America Biological Drugs Sales by Country (2018-2023) & (US$ Million)

Table 72. North America Biological Drugs Sales Market Share in Value by Country (2018-2023)

Table 73. North America Biological Drugs Sales by Country (2024-2029) & (Units)

Table 74. North America Biological Drugs Sales Market Share in Volume by Country (2024-2029)

Table 75. North America Biological Drugs Sales by Country (2024-2029) & (US$ Million)

Table 76. North America Biological Drugs Sales Market Share in Value by Country (2024-2029)

Table 77. Europe Biological Drugs Sales by Country (2018-2023) & (Units)

Table 78. Europe Biological Drugs Sales Market Share in Volume by Country (2018-2023)

Table 79. Europe Biological Drugs Sales by Country (2018-2023) & (US$ Million)

Table 80. Europe Biological Drugs Sales Market Share in Value by Country (2018-2023)

Table 81. Europe Biological Drugs Sales by Country (2024-2029) & (Units)

Table 82. Europe Biological Drugs Sales Market Share in Volume by Country (2024-2029)

Table 83. Europe Biological Drugs Sales by Country (2024-2029) & (US$ Million)

Table 84. Europe Biological Drugs Sales Market Share in Value by Country (2024-2029)

Table 85. Asia-Pacific Biological Drugs Sales by Region (2018-2023) & (Units)

Table 86. Asia-Pacific Biological Drugs Sales Market Share in Volume by Region (2018-2023)

Table 87. Asia-Pacific Biological Drugs Sales by Region (2018-2023) & (US$ Million)

Table 88. Asia-Pacific Biological Drugs Sales Market Share in Value by Region (2018-2023)

Table 89. Asia-Pacific Biological Drugs Sales by Region (2024-2029) & (Units)

Table 90. Asia-Pacific Biological Drugs Sales Market Share in Volume by Region (2024-2029)

Table 91. Asia-Pacific Biological Drugs Sales by Region (2024-2029) & (US$ Million)

Table 92. Asia-Pacific Biological Drugs Sales Market Share in Value by Region (2024-2029)

Table 93. Latin America Biological Drugs Sales by Country (2018-2023) & (Units)

Table 94. Latin America Biological Drugs Sales Market Share in Volume by Country (2018-2023)

Table 95. Latin America Biological Drugs Sales by Country (2018-2023) & (US$ Million)

Table 96. Latin America Biological Drugs Sales Market Share in Value by Country (2018-2023)

Table 97. Latin America Biological Drugs Sales by Country (2024-2029) & (Units)

Table 98. Latin America Biological Drugs Sales Market Share in Volume by Country (2024-2029)

Table 99. Latin America Biological Drugs Sales by Country (2024-2029) & (US$ Million)

Table 100. Latin America Biological Drugs Sales Market Share in Value by Country (2024-2029)

Table 101. Middle East and Africa Biological Drugs Sales by Country (2018-2023) & (Units)

Table 102. Middle East and Africa Biological Drugs Sales Market Share in Volume by Country (2018-2023)

Table 103. Middle East and Africa Biological Drugs Sales by Country (2018-2023) & (US$ Million)

Table 104. Middle East and Africa Biological Drugs Sales Market Share in Value by Country (2018-2023)

Table 105. Middle East and Africa Biological Drugs Sales by Country (2024-2029) & (Units)

Table 106. Middle East and Africa Biological Drugs Sales Market Share in Volume by Country (2024-2029)

Table 107. Middle East and Africa Biological Drugs Sales by Country (2024-2029) & (US$ Million)

Table 108. Middle East and Africa Biological Drugs Sales Market Share in Value by Country (2024-2029)

Table 109. Bristol-Myers Squibb Company Information

Table 110. Bristol-Myers Squibb Introduction and Business Overview

Table 111. Bristol-Myers Squibb Biological Drugs Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 112. Bristol-Myers Squibb Biological Drugs Product

Table 113. Bristol-Myers Squibb Recent Development

Table 114. Eli Lilly Company Information

Table 115. Eli Lilly Introduction and Business Overview

Table 116. Eli Lilly Biological Drugs Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 117. Eli Lilly Biological Drugs Product

Table 118. Eli Lilly Recent Development

Table 119. Takeda Company Information

Table 120. Takeda Introduction and Business Overview

Table 121. Takeda Biological Drugs Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 122. Takeda Biological Drugs Product

Table 123. Takeda Recent Development

Table 124. Pfizer Company Information

Table 125. Pfizer Introduction and Business Overview

Table 126. Pfizer Biological Drugs Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 127. Pfizer Biological Drugs Product

Table 128. Pfizer Recent Development

Table 129. Amgen Company Information

Table 130. Amgen Introduction and Business Overview

Table 131. Amgen Biological Drugs Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 132. Amgen Biological Drugs Product

Table 133. Amgen Recent Development

Table 134. F. Hoffmann-La Roche Company Information

Table 135. F. Hoffmann-La Roche Introduction and Business Overview

Table 136. F. Hoffmann-La Roche Biological Drugs Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 137. F. Hoffmann-La Roche Biological Drugs Product

Table 138. F. Hoffmann-La Roche Recent Development

Table 139. Johnson & Johnson Company Information

Table 140. Johnson & Johnson Introduction and Business Overview

Table 141. Johnson & Johnson Biological Drugs Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 142. Johnson & Johnson Biological Drugs Product

Table 143. Johnson & Johnson Recent Development

Table 144. Merck Company Information

Table 145. Merck Introduction and Business Overview

Table 146. Merck Biological Drugs Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 147. Merck Biological Drugs Product

Table 148. Merck Recent Development

Table 149. Abbott Laboratories Company Information

Table 150. Abbott Laboratories Introduction and Business Overview

Table 151. Abbott Laboratories Biological Drugs Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 152. Abbott Laboratories Biological Drugs Product

Table 153. Abbott Laboratories Recent Development

Table 154. Baxter Company Information

Table 155. Baxter Introduction and Business Overview

Table 156. Baxter Biological Drugs Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 157. Baxter Biological Drugs Product

Table 158. Baxter Recent Development

Table 159. Novartis Company Information

Table 160. Novartis Introduction and Business Overview

Table 161. Novartis Biological Drugs Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 162. Novartis Biological Drugs Product

Table 163. Novartis Recent Development

Table 164. Biogen Company Information

Table 165. Biogen Introduction and Business Overview

Table 166. Biogen Biological Drugs Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 167. Biogen Biological Drugs Product

Table 168. Biogen Recent Development

Table 169. GlaxoSmithKline Company Information

Table 170. GlaxoSmithKline Introduction and Business Overview

Table 171. GlaxoSmithKline Biological Drugs Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 172. GlaxoSmithKline Biological Drugs Product

Table 173. GlaxoSmithKline Recent Development

Table 174. Key Raw Materials Lists

Table 175. Raw Materials Key Suppliers Lists

Table 176. Biological Drugs Market Trends

Table 177. Biological Drugs Market Drivers

Table 178. Biological Drugs Market Challenges

Table 179. Biological Drugs Market Restraints

Table 180. Biological Drugs Distributors List

Table 181. Biological Drugs Downstream Customers

Table 182. Research Programs/Design for This Report

Table 183. Key Data Information from Secondary Sources

Table 184. Key Data Information from Primary Sources

List of Figures

Figure 1. Biological Drugs Product Picture

Figure 2. Global Biological Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Biological Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Biological Drugs Sales Status and Outlook (2018-2029) & (Units)

Figure 5. Product Picture of Therapeutic Protein

Figure 6. Global Therapeutic Protein Sales YoY Growth (2018-2029) & (Units)

Figure 7. Product Picture of Monoclonal Antibody

Figure 8. Global Monoclonal Antibody Sales YoY Growth (2018-2029) & (Units)

Figure 9. Product Picture of Vaccine

Figure 10. Global Vaccine Sales YoY Growth (2018-2029) & (Units)

Figure 11. Product Picture of Others

Figure 12. Global Others Sales YoY Growth (2018-2029) & (Units)

Figure 13. Global Biological Drugs Sales by Type (2018-2029) & (US$ Million)

Figure 14. Global Biological Drugs Sales Market Share by Type in 2022 & 2029

Figure 15. North America Biological Drugs Sales Market Share in Volume by Type in 2022

Figure 16. North America Biological Drugs Sales Market Share in Value by Type in 2022

Figure 17. Europe Biological Drugs Sales Market Share in Volume by Type in 2022

Figure 18. Europe Biological Drugs Sales Market Share in Value by Type in 2022

Figure 19. Asia-Pacific Biological Drugs Sales Market Share in Volume by Type in 2022

Figure 20. Asia-Pacific Biological Drugs Sales Market Share in Value by Type in 2022

Figure 21. Latin America Biological Drugs Sales Market Share in Volume by Type in 2022

Figure 22. Latin America Biological Drugs Sales Market Share in Value by Type in 2022

Figure 23. Middle East and Africa Biological Drugs Sales Market Share in Volume by Type in 2022

Figure 24. Middle East and Africa Biological Drugs Sales Market Share in Value by Type in 2022

Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Biological Drugs Sales in 2022

Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Biological Drugs Revenue in 2022

Figure 27. Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 28. Product Picture of Hospitals

Figure 29. Global Hospitals Sales YoY Growth (2018-2029) & (Units)

Figure 30. Product Picture of Ambulatory Surgical Centers

Figure 31. Global Ambulatory Surgical Centers Sales YoY Growth (2018-2029) & (Units)

Figure 32. Product Picture of Others

Figure 33. Global Others Sales YoY Growth (2018-2029) & (Units)

Figure 34. Global Biological Drugs Sales by Application (2018-2029) & (US$ Million)

Figure 35. Global Biological Drugs Sales Market Share by Application in 2022 & 2029

Figure 36. North America Biological Drugs Sales Market Share in Volume by Application in 2022

Figure 37. North America Biological Drugs Sales Market Share in Value by Application in 2022

Figure 38. Europe Biological Drugs Sales Market Share in Volume by Application in 2022

Figure 39. Europe Biological Drugs Sales Market Share in Value by Application in 2022

Figure 40. Asia-Pacific Biological Drugs Sales Market Share in Volume by Application in 2022

Figure 41. Asia-Pacific Biological Drugs Sales Market Share in Value by Application in 2022

Figure 42. Latin America Biological Drugs Sales Market Share in Volume by Application in 2022

Figure 43. Latin America Biological Drugs Sales Market Share in Value by Application in 2022

Figure 44. Middle East and Africa Biological Drugs Sales Market Share in Value by Application in 2022

Figure 45. Key Raw Materials Price

Figure 46. Biological Drugs Manufacturing Cost Structure

Figure 47. Biological Drugs Industrial Chain Analysis

Figure 48. Channels of Distribution

Figure 49. Distributors Profiles

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Veterinary Drugs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31X6782

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Coating Devcie Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7E13021

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Animal Antibacterial Peptide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20G6893

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Medical Biological Indicator Incubator Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34Y12560

Fri May 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions